Wordt geladen...
New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib
Until recently, few treatment options existed for the treatment of squamous cell carcinoma (SqCC) of the lung, especially in the second-line setting following platinum-based chemotherapy. Accordingly, outcomes in this subtype of non-small-cell lung cancer (NSCLC) were generally poor. In this context...
Bewaard in:
| Gepubliceerd in: | Onco Targets Ther |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5436789/ https://ncbi.nlm.nih.gov/pubmed/28546756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S104177 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|